Abstract
C17H16O2, monoclinic, P21/c (no. 14), a = 11.6963(12) Å, b = 11.1187(8) Å, c = 11.6902(10) Å, β = 115.545(7)°, V = 1371.7(2) Å3, Z = 4, Rgt(F) = 0.0350, wRref(F2) = 0.0865, T = 293 K.
The asymmetric unit of the title crystal structure is shown in the figure. Tables 1 and 2 contain details of the measurement method and a list of the atoms including atomic coordinates and displacement parameters.
Crystal: | Colourless prism |
Size: | 0.36 × 0.27 × 0.12 mm |
Wavelength: | Mo Kα radiation (0.71073 Å) |
μ: | 0.8 cm−1 |
Diffractometer, scan mode: | STOE IPDS 2, ω scans |
2θmax, completeness: | 52°, 98.8% |
N(hkl)measured, N(hkl)unique, Rint: | 7194, 2661, 0.037 |
Criterion for Iobs, N(hkl)gt: | Iobs > 2 σ(Iobs), 1375 |
N(param)refined: | 236 |
Programs: | Stoe programs [1], SHELX [2, 3] , ORTEP [4] |
Atom | x | y | z | Uiso*/Ueq |
---|---|---|---|---|
C1 | 0.36180(15) | 0.32004(16) | 0.61559(16) | 0.0787(4) |
C2 | 0.43587(15) | 0.27272(15) | 0.73366(16) | 0.0788(4) |
C3 | 0.41923(13) | 0.15512(14) | 0.75852(14) | 0.0729(4) |
C4 | 0.32929(16) | 0.08557(15) | 0.66461(16) | 0.0814(5) |
C5 | 0.25615(15) | 0.13408(14) | 0.54835(16) | 0.0749(4) |
C6 | 0.27015(13) | 0.25269(13) | 0.52017(13) | 0.0660(4) |
C7 | 0.19122(15) | 0.30866(15) | 0.39781(15) | 0.0740(4) |
C8 | 0.10143(15) | 0.25798(15) | 0.29722(15) | 0.0734(4) |
C9 | 0.02624(13) | 0.32677(13) | 0.18103(13) | 0.0704(4) |
C10 | −0.05096(13) | 0.26101(12) | 0.06163(13) | 0.0662(4) |
C11 | −0.10413(15) | 0.32522(16) | −0.05156(16) | 0.0763(4) |
C12 | −0.17460(16) | 0.26820(16) | −0.16466(16) | 0.0798(5) |
C13 | −0.19631(13) | 0.14563(15) | −0.17099(14) | 0.0730(4) |
C14 | −0.14285(15) | 0.08265(16) | −0.05865(16) | 0.0779(4) |
C15 | −0.07184(14) | 0.13783(13) | 0.05549(17) | 0.0746(4) |
C16 | −0.2733(2) | 0.0836(2) | −0.2941(2) | 0.0986(6) |
C17 | 0.5723(2) | 0.1671(2) | 0.9754(2) | 0.0991(6) |
O1 | 0.48553(10) | 0.09799(10) | 0.87164(10) | 0.0952(4) |
O2 | 0.02810(11) | 0.43693(9) | 0.18209(9) | 0.0926(4) |
H1 | 0.3737(14) | 0.4032(15) | 0.5996(13) | 0.093(5)* |
H2 | 0.4969(14) | 0.3226(13) | 0.7989(14) | 0.091(5)* |
H4 | 0.3196(15) | 0.0037(15) | 0.6841(14) | 0.104(5)* |
H5 | 0.1935(13) | 0.0848(12) | 0.4841(13) | 0.081(4)* |
H7 | 0.2070(13) | 0.3943(13) | 0.3907(12) | 0.085(4)* |
H8 | 0.0821(13) | 0.1756(14) | 0.2962(12) | 0.082(4)* |
H11 | −0.0863(14) | 0.4102(15) | −0.0479(14) | 0.097(5)* |
H12 | −0.2063(13) | 0.3136(13) | −0.2413(14) | 0.085(5)* |
H14 | −0.1552(13) | −0.0036(14) | −0.0611(13) | 0.092(5)* |
H15 | −0.0377(13) | 0.0903(13) | 0.1305(13) | 0.081(4)* |
H17A | 0.6045(19) | 0.1107(18) | 1.048(2) | 0.143(8)* |
H17B | 0.6404(18) | 0.2026(17) | 0.9546(16) | 0.129(7)* |
H17C | 0.5260(16) | 0.2375(17) | 0.9895(14) | 0.113(6)* |
H18A | −0.362(2) | 0.100(2) | −0.325(2) | 0.173(10)* |
H18B | −0.267(2) | −0.001(2) | −0.290(2) | 0.159(9)* |
H18C | −0.251(2) | 0.1087(19) | −0.361(2) | 0.159(9)* |
Source of material
Equimolar quanities of p-methylacetophenone (0.01 mol) and p-methoxybenzaldehyde (0.01 mol) were dissolved in ethanol (10 mL) under stirring and aq. NaOH (30%) was added dropwise. The reaction mixture was stirred at room temperature for a few hours. The reaction mixture was diluted with water & acidifed with HCl. The separated solid was filtered and recrystallised from ethanol [5].
IR (ATR) cm−1: 2932 (aromatic—CH), 2837 (aliphatic—CH), 1651 (C = O), 1593–1416 (C = C); 1H-NMR (δ): 8.00–6.94 (−CH), 2.41 (−CH3), 3.91 (−OCH3); 13C-NMR (δ): 21.54 (−CH3), 55.51 (−OCH3), 188 (C = O), 163 (HC = CH), 144–120 (aromatic—CH3), 113.81–113.75 (aliphatic—CH). Anal. Calcd. for C17H16O2: C, 80.95; H, 6.34; Found: C, 80.63; H, 6.07.
Experimental details
The structure was solved by direct methods and refined by full-matrix least-square techniques. All the H atoms in the molecular structure were found and located in difference Fourier map and refined freely. H bond lengths vary between 0.952(14) Å and 0.969(15) Å for aromatic rings.
Comment
Chalcones consist of two aromatic rings which are linked by three carbon atoms with a α,β-unsaturated carbonyl system. Chalcones and their derivatives are interesting materials for their biological activities such as anti-viral, anti-malarial, anti-cancer, antioxidant, anti-inflammatory, antifungal, antileishmanial, anti-tubercular, anti-hyperglycemic properties [6], [7], [8], [9], [10], [11]. They are also used in different applications such as agriculture [12], cosmetics and manufacture of pesticides [13].
The title compund, C17H16O2, shows E conformation with respect to the C = C double bond (C7 = C8 = 1.318(2) Å). In the molecular structure, the methoxy substituted phenyl ring and the methyl substituted phenyl ring are inclined by 13.78(6)°. The maximum deviations within the ring systems are 0.0052(2) Å for C4 atom of the C1—C6 ring and 0.0033(2) Å for atom C12 of the C10—C15 ring. The attached methyl group is co-planar with the related aromatic ring system (C10—C15). The methoxy group is slightly twisted with the C4—C3—O1—C17 and C2—C3—O1—C17 torsion angles of −174.97(16)° and 5.0(2)°, respectively. In the molecular structure, the bond lengths and angles are consistent with the related structures [14, 15] . The crystal structure presents at least one very weak intermolecular hydrogen bond, namely C11—H11⋯O2′ (with symmetry code: −x, −y + 1, −z).
Acknowledgement
The related single crystal X-Ray data was collected in Faculty of Arts and Sciences, Ondokuz Mayıs University, Turkey, by using Stoe IPDS II diffractometer and deposited with the CCDC number of 1515321.
References
1 Stoe&Cie. X-AREA (Version 1.18) and X-RED32 (Version1.04). Stoe&Cie, Darmstadt, Germany, 2002.Search in Google Scholar
2 Sheldrick, G. M.: A short history of SHELX. Acta Crystallogr. A64 (2008) 112–122.10.1107/S0108767307043930Search in Google Scholar PubMed
3 Sheldrick, G. M.: Crystal structure refinement with SHELXL. Acta Crystallogr. C71 (2015) 3–8.10.1107/S2053229614024218Search in Google Scholar PubMed PubMed Central
4 Farrugia, L. J.: WinGX and ORTEP for Windows: an update. J. Appl. Cryst. 45 (2012) 849–854.10.1107/S0021889812029111Search in Google Scholar
5 Jadhav, S. A.; Kulkarni, K. M.; Patil, P. B.; Dhole, V. R.; Patil, S. S.: Design, synthesis and biological evaluation of some novel pyrazoline derivatives. Der Pharma Chemica 8 (2016) 38–45.Search in Google Scholar
6 Arias-Ruiz, S. N.; Romero, N.; Lobato-García, C. E.; Gómez-Rivera, A.; Mendoza, A.: Second monoclinic form of (E)-3-(4-fluorophenyl)-1-phenylprop-2-en-1-one. Acta Crystallogr. E69 (2013) o1694–o1695.10.1107/S1600536813028079Search in Google Scholar PubMed PubMed Central
7 Dimmock, J. R.; Elias, D. W.; Beazely, M. A.; Kandepu, N. M.: Bioactivities of chalcones. Curr. Med. Chem. 6 (1999) 1125–1149.10.2174/0929867306666220401182509Search in Google Scholar
8 Nowakowska, Z.: A review of anti-infective and anti-inflammatory chalcones. Eur. J. Med. Chem. 42 (2007) 125–137.10.1016/j.ejmech.2006.09.019Search in Google Scholar PubMed
9 Zhang, X.-W.; Zhao, D.-H.; Quan, Y.-C.; Sun, L.-P.; Yin, X.-M.; Guan, L.-P.: Synthesis and evaluation of antiinflammatory activity of substituted chalcone derivatives. Med. Chem. Res. 19 (2010) 403–412.10.1007/s00044-009-9202-zSearch in Google Scholar
10 Kouskoura, M.; Hadjipavlou-Litina, D.; Giakoumakou, M.: Synthesis and anti-inflammatory activity of chalcones and related mannich bases. Med.Chem. 4 (2008) 586–596.10.2174/157340608786242070Search in Google Scholar PubMed
11 Doan, T. N.; Tran, D. T.: Synthesis, antioxidant and antimicrobial activities of a novel series of chalcones, pyrazolic chalcones, and allylic chalcones. Pharmacol. Pharmacy 2 (2011) 282–288.10.4236/pp.2011.24036Search in Google Scholar
12 Pasquale, G.; Romanelli, G. P.; Autino, J. C.; García, J.; Ortiz, E. V.; Duchowicz, P. R.; Agric, J.: Quantitative structure-activity relationships of mosquito larvicidal chalcone derivatives. J. Agric. Food Chem. 60 (2012) 692–697.10.1021/jf203374rSearch in Google Scholar PubMed
13 Bhavana, P.; Sarveswari, S.; Weng Ng, S.; Tiekink, E. R. T.: Efficient ultrasound-assisted synthesis, spectroscopic, crystallographic and biological investigations of pyrazole-appended quinolinyl chalcones. J. Mol. Struct. 1081 (2015) 201–210.10.1016/j.molstruc.2014.10.026Search in Google Scholar
14 Ahn, S.; Lee, H. J.; Lim, Y.; Koh, D.: (E)-1-(3,5-Dimethoxyphenyl)-3-(3-methoxyphenyl)prop-2-en-1-one. Acta Crystallogr. E69 (2013) o666–o666.10.1107/S1600536813008982Search in Google Scholar PubMed PubMed Central
15 Ezhilarasi, K. S.; Jonathan, D. R.; Sathya, S.; Prathebha, K.; Usha, G.: (2E)-1-(3,5-Dihydroxyphenyl)-3-(4-methoxyphenyl)prop-2-en-1-one. Acta Crystallogr. E70 (2014) o608–o609.10.1107/S1600536814009155Search in Google Scholar PubMed PubMed Central
©2017 Yavuz Köysal et al., published by De Gruyter.
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.